Branden Ryu

Branden Ryu

Company: Biorchestra

Job title: Founder & Chief Executive Officer


Panel Discussion: Exploring the Toxicity and Immunogenicity of Polymers in Comparison to Other Delivery Vehicles Available to Industry 2:45 pm

Debating the potential negative side effects associated with polymeric toxicity despite the tailored delivery benefits developed, proving challenging to push through to clinical trails Researching the potential for overcoming polymer-related immune responses that exhibit less potent immunogenicity Assessing whether complete immunosuppression is a realistic challenge to overcome in polymer delivery vehicles and therefore posing the…Read more

day: Conference Day One

C-suite Fireside Chat – Reviewing the Polymeric Drug Delivery Landscape for 2024 9:30 am

An exclusive opportunity to hear from the C-Suite thought leaders at the forefront of polymeric innovations across the biotech landscape. An insightful discussion reviewing the latest developments in the space and an eye to what the future holds across this stimulating field of science.Read more

day: Conference Day Two

Brain Target Delivery of RNA Therapeutics using the Polymeric Micelle 11:15 am

Biorchestra Drug Delivery System (BDDSTM) is a proprietary technology utilizing nonlipid polymer ion complex and brain targeting technology. Design and synthesis of target and non-target polymers will be discussed. BDDSTM technology is compatible with multiple RNA species with various length (e.g., ASO, siRNA & mRNA). Application of RNA encapsulating BDDSTM in animal models of several…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.